We are live on ! Find out more
PAM

Paradigm Asset Management Portfolio holdings

AUM $426M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+18.16%
3 Year Est. Return
+51.62%
5 Year Est. Return
+67.65%
10 Year Est. Return
+240.73%
AUM
$495M
AUM Growth
-$30M
Cap. Flow
-$42.4M
Cap. Flow %
-8.57%
Top 10 Hldgs %
9.93%
Holding
703
New
53
Increased
91
Reduced
292
Closed
120

Top Buys

Rank Stock Value
1
EXC icon
Exelon
EXC
+$4.65M
2
KEY icon
KeyCorp
KEY
+$4.42M
3
AMG icon
Affiliated Managers Group
AMG
+$3.9M
4
PLD icon
Prologis
PLD
+$3.78M
5
JPM icon
JPMorgan Chase
JPM
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 19.33%
2 Healthcare 10.35%
3 Energy 9.4%
4 Industrials 8.24%
5 Technology 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
426
DELISTED
Acorda Therapeutics
ACOR
$43.3K 0.01%
18
-20
-53% -$39.6K
AMSF icon
427
AMERISAFE
AMSF
$543M
$39.9K 0.01%
700
-2,500
-78% -$143K
EXPD icon
428
Expeditors International
EXPD
$22B
$39.5K 0.01%
700
-300
-30% -$16.5K
ACAD icon
429
Acadia Pharmaceuticals
ACAD
$4.43B
$39K 0.01%
1,400
-1,500
-52% -$44.7K
AQMS icon
430
Aqua Metals
AQMS
$8.99M
$38.9K 0.01%
16
-16
-50% -$45.3K
HUM icon
431
Humana
HUM
$43.7B
$36.1K 0.01%
150
CRR
432
DELISTED
Carbo Ceramics Inc.
CRR
$35.6K 0.01%
5,200
-5,400
-51% -$44.4K
XPO icon
433
XPO
XPO
$23.5B
$35.5K 0.01%
1,590
-5,783
-78% -$108K
TECH icon
434
Bio-Techne
TECH
$11.2B
$35.3K 0.01%
1,200
-612
-34% -$16.7K
GMED icon
435
Globus Medical
GMED
$10.7B
$34.8K 0.01%
1,050
-4,350
-81% -$137K
IRBT
436
DELISTED
iRobot
IRBT
$33.7K 0.01%
400
+50
+14% +$4.31K
SNBR
437
DELISTED
Sleep Number
SNBR
$31.9K 0.01%
900
-650
-42% -$19.4K
PGNX
438
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$30.6K 0.01%
4,500
-4,600
-51% -$34K
REV
439
DELISTED
Revlon, Inc.
REV
$28.4K 0.01%
1,200
-2,550
-68% -$57.9K
ANDV
440
DELISTED
Andeavor
ANDV
$28.1K 0.01%
300
-150
-33% -$12.7K
PHX
441
DELISTED
PHX Minerals
PHX
$27.7K 0.01%
+1,200
New +$24.4K
PANW icon
442
Palo Alto Networks
PANW
$270B
$26.8K 0.01%
1,200
-2,400
-67% -$48.5K
CTRN icon
443
Citi Trends
CTRN
$555M
$26.5K 0.01%
+1,250
New +$23.6K
CMP icon
444
Compass Minerals
CMP
$1.23B
$26.1K 0.01%
400
-850
-68% -$56.6K
OFLX icon
445
Omega Flex
OFLX
$297M
$25.8K 0.01%
+400
New +$23.1K
DBD
446
DELISTED
Diebold Nixdorf Incorporated
DBD
$25.2K 0.01%
900
-472
-34% -$13.1K
SRGA
447
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$25.2K 0.01%
+143
New +$20.3K
STBA icon
448
S&T Bancorp
STBA
$1.84B
$25.1K 0.01%
+700
New +$24.5K
HOLX
449
DELISTED
Hologic
HOLX
$25K 0.01%
+550
New +$24.3K
HBAN icon
450
Huntington Bancshares
HBAN
$34.4B
$24.3K ﹤0.01%
+1,800
New +$23.3K

Similar funds

Paradigm Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Paradigm Asset Management held 703 positions worth $495M, down 5.7% from $525M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Paradigm Asset Management withdrew a net $42.4M in Q2 2017, closing 120 positions and reducing 292 holdings. Its most notable exit was Citigroup, an estimated $9.77M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Paradigm Asset Management opened a new position in Affiliated Managers Group worth $4.05M.

  • Paradigm Asset Management's largest Q2 2017 buy was Affiliated Managers Group: 24,400 shares worth $4.05M.
  • Paradigm Asset Management added most to Exelon in Q2 2017, an estimated $4.65M increase.
  • Paradigm Asset Management's biggest Q2 2017 reduction was Fifth Third Bancorp, cutting an estimated $3.48M.
  • Paradigm Asset Management fully exited Citigroup in Q2 2017, selling an estimated $9.77M.
  • Paradigm Asset Management's ten largest holdings make up 9.9% of its $495M portfolio in Q2 2017.
  • Paradigm Asset Management opened 53 new positions and closed 120 in Q2 2017.
  • Paradigm Asset Management's portfolio value fell 5.7% quarter-over-quarter to $495M.

Based on Paradigm Asset Management's 13F filing for Q2 2017, filed 7 Aug 2017.